US 2016/0235789 A1Published application

Bone Marrow Origin Progenitor Cell or Endothelial Progenitor Cell in Combination with DNMT1 Gene Therapy for Vascular Repair in Metabolic Disease

AssigneeTemple University of the Commonwealth System of Higher Education

InventorHong Wang

Life of this patent

Estimating the term…

Abstract

The present invention provides an isolated population of bone marrow-derived endothelial progenitor cells (EPCs) and uses thereof for the treatment of vascular diseases.

Claims12

Dependent claims

A method of treating a vascular disease in a subject, the method comprising administering to a subject in need thereof an effective amount of bone marrow-derived endothelial progenitor cells (EPCs) to the subject in need thereof.

Dependencies are inferred from the claim text.

Facts

Application: 15/044,859Filed 16 Feb 2016
Priority: 13 Feb 2015
Published: 18 Aug 2016
Term ends: Not estimatedThe source records don’t support an estimate.

Classification6 codes

A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A61K 35/28
Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically…:…
A61K 48/00
Medicinal preparations containing genetic material which is inserted into cells of the
C12N 5/0692
Vascular Endothelial cells: stem cells; Progenitor cells; Precursor cells

Family

Application62/115,979Us provisional application · filed 13 Feb 2015
US 9,901,639 B2Related patent
US 2016/0235789 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results